InstantRx™ Vaccine Price
InstantRx™ is a digital gateway empowering people to easily find lower-priced medicines and vaccines.
Vaccine Price For Children
The U.S. CDC Price List was updated on July 1, 2022, highlighting current antiviral and vaccine contracts and private sector vaccine prices. The Vaccines For Children (VFC) program is a federally funded service that provides vaccines at no cost to qualifying children. Eligible children for VFC vaccines are entitled to receive those vaccines recommended by the U.S. CDC.
COVID-19 Vaccine Price For Children
Through the U.S. government-funded VFC and COVID-19 Vaccination programs, children can receive vaccines at no charge. However, this CDC table assists VFC providers in understanding the difference in the programs' requirements.
Vaccine Price Information For 2022
Vaccine Price For Seniors
The Inflation Reduction Act of 2022 eliminates out-of-pocket costs for vaccines under Medicare Part D. This Act aligns with policies under Medicare Part B and the Affordable Care Act and removes pharmacy counter barriers that should result in more seniors being vaccinated. Consumers can also visit BeSafeRx to learn how to buy medicine online safely.
Vaccine Co-Payment Relief Program
The Patient Advocate Foundation's Co-Pay Relief program exists to help reduce the financial distress patients and their families face when paying for treatment. CPR’s Health Equity Funds are specifically designed to provide assistance to eligible patients living in one of the 220 counties covered by the funds.
Medications and Vaccine Discounts For 2022
ArrayRx - A collaboration of state partners (Nevada, Oregon, Washington) offering the ArrayRx prescription discount card.
BlinkRx - A digital pharmacy that provides your lowest prescription price. Pick up your medication at participating pharmacies nationwide or with home delivery.
Brookshire's yourpoints with every prescription you fill at Brookshire's.
ConnectiveRx helps pharmaceutical manufacturers, healthcare providers, and patients by facilitating access to needed medications.
Eli Lilly's Lilly Cares® Foundation Patient Assistance Program provides prescribed Lilly medications for free to qualifying U.S. patients. In addition, for those who don't have insurance, there are programs available to help people who qualify obtain the Lilly medicines they need at a lower cost or no cost.
GoodRx - Stop paying too much for your prescriptions. Compare prices, find free coupons, and save up to 80%.
Mark Cuban Cost Plus Drug Company - A radically transparent online pharmacy is battling retail prescription costs.
MarketStreet United offers rewards for savings at checkout and the pump, plus enjoy access to online shopping, digital coupons, and Insider Perks.
RxSaver - Since 2009, RxSaver's prescription savings program has been available to consumers from a website, mobile app, and prescription savings card.
Pfizer PAP Connect is designed to simplify how patients can access certain Pfizer medicines through the Pfizer Patient Assistance Program.
Sanofi Patient Connection® offers various vaccine price savings subject to Eligibility and restrictions. In addition, Sanofi has live support specialists at (800) 633-1610 to answer patients' questions.
SingleCare - Save up to 80% on your prescriptions with SingleCare prescription coupons and compare Rx prices from local pharmacies to get the best prescription price.
Discount Medicine and Vaccine News For 2022
September 20, 2022 - The Current State of Hospital Finances: Fall 2022 Update - labor costs Vs. medication/vaccine prices.
September 13, 2022 - The Drug Channels published: The Inflation Reduction Act: Three Unintended Consequences for Biosimilars, Health Plans, Providers, and Pharmacies
August 19, 2022 - The U.S. administration is planning to stop paying for COVID-19 products and transition to a standard purchasing process through different health care system channels, including commercial insurers and pharmacy benefit managers.
July 26, 2022 - Warped Incentives Update: The Gross-to-Net Bubble Exceeded $200 Billion in 2021.
July 2022 - The top 15 therapeutic classes by spending accounted for more than 74% of the $198.6 billion spent on prescription drugs in 2020 were covered by Part D plans.
June 21, 2022 - The Annals of Internal Medicine published: Potential Medicare Part D Savings on Generic Drugs From the Mark Cuban Cost Plus Drug Company.
May 24, 2022 - GoodRx disclosed that Kroger accounts for about 25% of its prescription business. The GoodRx situation highlights crucial issues about the complex web of relationships and conflicts that support today's discount card model.
May 10, 2022 - The Drug Channels' annual update on pricing. When rebates and discounts were factored in, brand-name drug prices declined—or grew slowly—in 2021. What's more, average net drug prices have declined for the past five years, although a few companies had net price gains or slower declines in 2021.
May 2, 2022 - GoodRx announced a new effort with AssistRx to bring broader awareness and access to branded and specialty medication therapy initiation. AssistRx's iAssist platform enables providers immediate access to a patient's coverage, improved price transparency, and the right prior authorization information.
April 21, 2022 - The Use of Medicines in the U.S. 2022 report revealed that patient out-of-pocket costs in aggregate rose 5.3% in 2021 to a total of $79 billion, back to the level seen in 2018.
April 12, 2022 - Janssen U.S. Pharmaceutical reported declining net prices by -2.8% and nearly -17% when compounded over the last six years. Nearly 55% of the list price of our medicines went to commercial insurers and others in the healthcare system as rebates, discounts, and fees.
April 1, 2022 - Leader's Edge caught up with Mark Cuban Cost Plus Drug Company co-founder Alex Oshmyansky and Ron Harrison at The Council's Legislative & Working Groups Summit to hear about its goal to curb drug costs by working both as a retailer and its own PBM.
March 22, 2022 - Drug Channels Institute's annual update included the gross-to-net bubble, the dollar gap between sales at brand-name drugs' list prices, and their net prices after rebates and other reductions, which is estimated to reach $204 billion in 2021. This bubble creates patient affordability challenges.
March 8, 2022 - The Top 15 U.S. Pharmacies of 2021: Market Shares and Revenues.
March 1, 2022 - The Centers for Medicare & Medicaid Services recently released its 2022 data on enrollment in Medicare Part D prescription drug plans (PDPs). Adam J. Fein, Ph.D.'s exclusive analysis of these numbers, finds that for 2022, an astounding 99% of seniors are enrolled in PDPs with preferred pharmacy networks.
February 25, 2022 - 'Solving the Copay and Best Price Challenge' written by Jason Zemcik, Vice President, Patient Affordability, TrialCard.
February 22, 2022 - The 2022 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers is a definitive, nonpartisan resource that includes the most current information about pharmacy dispensing channels. A free preview is available at this link.
February 15, 2022 - New York-based Ro announced it had raised an additional $150 million. Zachariah Reitano, Co-Founder & CEO of Ro, commented: "In less than five years, Ro has become the only company to combine nationwide telemedicine, in-home care, diagnostics, labs, and pharmacy services."
February 9, 2022 - A leading virtual specialty health company, Thirty Madison, with over 750k active patients, expects to produce $300M in revenue in 2022.
February 8, 2022 - In the CoverMyMeds annual report, learn what challenges patients faced accessing medications in 2021.
February 2, 2022 - GoodRx's CEO Doug Hirsch published an article: Why lowering drug prices is harder than it looks.
February 1, 2022 - Still Not Skyrocketing: New CMS Data Reinforce the Truth About U.S. Drug Spending.
September 10, 2020 - The WSJ published a Commentary By Adam J. Fein: The Federal Program That Keeps Insulin Prices High.... enabling middlemen to pocket discounts.
Travel Vaccines For 2022
Vax-Before-Travel offers international travelers access to vaccination appointment services in select markets.
Note: InstantRx™ is owned by Precision Vaccinations LLC, which may receive compensation for connecting people with third parties. InstantRx has been in commercial use for over ten years, pending a trademark.